Levicept Completes Recruitment in Phase II Clinical Trial of Neurotrophin Modulator LEVI-04
December 13, 2023 04:00 ET | Levicept
SANDWICH, United Kingdom, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for chronic pain indications,...
Levicept Appoints Eliot Forster as CEO
November 30, 2023 04:00 ET | Levicept
Leadership Team Strengthened as Clinical Development of LEVI-04 a Novel Neurotrophin Modulator for Osteoarthritis and Chronic Pain Advances SANDWICH, United Kingdom, Nov. 30, 2023 (GLOBE NEWSWIRE)...